methylarsonite

structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Douillet, Christelle: 2 articles (12/2017 - 02/2013)
2.	Stýblo, Miroslav: 2 articles (12/2017 - 02/2013)
3.	Del Razo, Luz M: 2 articles (11/2011 - 03/2005)
4.	Valenzuela, Olga L: 2 articles (11/2011 - 03/2005)
5.	Fennel, Emily M J: 1 article (12/2017)
6.	Zhang, Chongben: 1 article (12/2017)
7.	Bodnar, Wanda M: 1 article (02/2013)
8.	Currier, Jenna: 1 article (02/2013)
9.	Matoušek, Tomáš: 1 article (02/2013)
10.	Saunders, Jesse: 1 article (02/2013)

1.	Neoplasms (Cancer) 11/01/2011 - "Metabolic conversions of iAs that yield highly toxic and genotoxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII) may play a significant role in determining the extent and character of toxic and cancer-promoting effects of iAs exposure. " 03/01/2005 - "Metabolic conversions of iAs that yield highly toxic and genotoxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII) may play a significant role in determining the extent and character of toxic and cancer-promoting effects of iAs exposure. "
2.	Insulin Resistance 12/01/2017 - "Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes." 02/15/2013 - "We have previously shown that micromolar concentrations of arsenite (iAs(III)) or its methylated trivalent metabolites, methylarsonite (MAs(III)) and dimethylarsinite (DMAs(III)), inhibit the insulin-activated signal transduction pathway, resulting in insulin resistance in adipocytes. "